2023-11-06 13:53:00
José Luis Arroyo, responsible for Quality Management at the Cantabria Blood and Tissue Bank, has participated in the Educational Program of the National Congress of Hematology, Hemotherapy, Thrombosis and Haemostasis, #Hemato2023. The expert has reviewed the scientific and technological advances that have taken place in recent decades in the field of transfusion medicine. Also your involvement in the centers’ activity and current transfusion services. “As in other branches of Hematology, extraordinary advances have been made in transfusion medicine in recent years, both from the point of view of theoretical knowledge and technological aspects and their application in clinical practice,” says Arroyo. “These advances revolve around three lines of research: availability of blood and blood components, increased quality and safety of available componentsand optimal use of blood.”
Advances in transfusion medicine
In the field of safety, the specialist highlights the “pathogen attenuation techniques (also known as inactivation techniques), because they have represented a paradigm shift in the approach to the infectious risk associated with transfusion, moving from a reactive model to a proactive model. Thanks to this strategy, programs to obtain COVID-19 convalescent plasma might be developed from the earliest phase of the pandemic.” In this sense, Arroyo explains that, “without a doubt, blood is safer than ever, largely thanks to improvements in the detection of communicable viral diseases.” Recently, efforts are focusing on bacterial contamination of platelets and non-infectious risks, errors during the transfusion process or actions once morest emerging diseases. Regarding the future of transfusion medicine, the expert contributes that “transfusion centers and services have been looking beyond their traditional functions and activities for years to develop their activity and expand their mission. In factcell therapy represents a natural field for this expansion, as is becoming evident with the arrival of CAR-T. Another great challenge in this area is to improve the sufficiency of plasma-derived medicines,” he concludes.
1699289287
#keys #safety #transfusion #medicine
